TheProfitWatch

TERN - Terns Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.2 0.45 (5.47%) --- --- --- 0.2 (2.44%) 0.27 (3.28%) 0.0 (0.0%) 0.0 (0.0%)

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.26
Diluted EPS:
-0.26
Basic P/E:
-33.2642
Diluted P/E:
-33.2642
RSI(14) 1m:
100.0
VWAP:
8.65
RVol:
0.6611

Events

Period Kind Movement Occurred At

Related News